| Identification | Back Directory | [Name]
Propanoic acid, 2-[4-[(1E)-3-(2-methoxy-3-quinolinyl)-3-oxo-1-propen-1-yl]-2,6-dimethylphenoxy]-2-methyl- | [CAS]
2340432-40-6 | [Synonyms]
Pparδ agonist 7 Propanoic acid, 2-[4-[(1E)-3-(2-methoxy-3-quinolinyl)-3-oxo-1-propen-1-yl]-2,6-dimethylphenoxy]-2-methyl- | [Molecular Formula]
C25H25NO5 | [MOL File]
2340432-40-6.mol | [Molecular Weight]
419.47 |
| Hazard Information | Back Directory | [Uses]
Pparδ agonist 7 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 7 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2019105234A1, compound TM4)[1]. | [References]
[1] Jiawang Zhu, et al. Aromatic compounds and pharmaceutical compositions and uses thereof. Patent WO2019105234A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|